Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress
Part of paid clinical trials in Durham, North Carolina.
- Sponsor
- Duke University
- Study ID
- NCT06999109
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Dermatomyositis
- Dermatomyositis, Juvenile
- Lupus
- Lupus Erythematosus
- Lupus Erythematosus, Systemic
- Lupus or SLE
Eligibility Criteria
- Sex
- ALL
- Age
- 13 Years - 22 Years
- Healthy Volunteers
- Not accepted
Interventions
- TEAM-LEADS — BEHAVIORALTEAM-LEADS will be an online, self-administered intervention for stress reduction and cardiovascular health behavior promotion in adolescents and young adults with juvenile-onset systemic lupus erythematosus and dermatomyositis
Study Details
The objectives of this study are to determine if the 'Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress' (TEAM-LEADS) intervention is feasible and acceptable to adolescents and young adults with lupus and dermatomyositis and whether it can help reduce stress and promote cardiovascular health behaviors in these individuals.
Key Dates
- Start date
- Feb 1, 2027
- Status verified
- May 2026
- Primary completion
- Oct 23, 2028
- Completion
- Jan 15, 2029
Study Design
- Enrollment
- 25 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: TEAM-LEADS intervention arm
Primary Outcome Measure
Change in Patient-Reported Outcome Measures Information System (PROMIS) Pediatric Psychological Stress Experiences (version 1.0 Short Form 8a) T-scores [ Time Frame: From T1 (baseline visit, day 0) to T3 (Day 84) ]
Central Contacts
- Kaveh Ardalan, MD, MS919-684-6575
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Duke University Medical Center | Durham | North Carolina | 27710 | Kaveh Ardalan, MD, MS (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Durham, NC
Related Studies
- Adult and Juvenile MyositisRecruiting · National Institute of Environmental Health Sciences (NIEHS) · Atlanta, Georgia
- Environmental Risk Factors for the Anti-synthetase SyndromeRecruiting · National Institute of Environmental Health Sciences (NIEHS) · Miami, Florida
- A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory MyopathyPHASE3 · Enrolling By Invitation · argenx · Phoenix, Arizona
- RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory MyopathyPHASE2/PHASE3 · Recruiting · Cabaletta Bio · Orange, California